| molecular function |
|---|
| | GO:0070063 | | RNA polymerase binding | | Interacting selectively and non-covalently with an RNA polymerase molecule or complex. |
| | GO:0031698 | | beta-2 adrenergic receptor binding | | Interacting selectively and non-covalently with a beta-2 adrenergic receptor. |
| | GO:0016874 | | ligase activity | | Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. |
| | GO:0050815 | | phosphoserine residue binding | | Interacting selectively and non-covalently with a phosphorylated serine residue within a protein. |
| | GO:0050816 | | phosphothreonine residue binding | | Interacting selectively and non-covalently with a phosphorylated threonine residue within a protein. |
| | GO:0070064 | | proline-rich region binding | | Interacting selectively and non-covalently with a proline-rich region, i.e. a region that contains a high proportion of proline residues, in a protein. |
| | GO:0008022 | | protein C-terminus binding | | Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxy function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0019904 | | protein domain specific binding | | Interacting selectively and non-covalently with a specific domain of a protein. |
| | GO:0019871 | | sodium channel inhibitor activity | | Stops, prevents, or reduces the activity of a sodium channel. |
| | GO:0043130 | | ubiquitin binding | | Interacting selectively and non-covalently with ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. |
| | GO:0061630 | | ubiquitin protein ligase activity | | Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues. |
| | GO:0004842 | | ubiquitin-protein transferase activity | | Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages. |
| biological process |
|---|
| | GO:0042110 | | T cell activation | | The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
| | GO:0002250 | | adaptive immune response | | An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
| | GO:0048514 | | blood vessel morphogenesis | | The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood. |
| | GO:0034644 | | cellular response to UV | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
| | GO:0044111 | | development involved in symbiotic interaction | | The progression of an organism from an initial condition to a later condition, occurring when the organism is in a symbiotic interaction. |
| | GO:0003197 | | endocardial cushion development | | The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. |
| | GO:0042921 | | glucocorticoid receptor signaling pathway | | Any series of molecular signals generated as a consequence of a glucocorticoid binding to its receptor. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0007041 | | lysosomal transport | | The directed movement of substances into, out of or within a lysosome. |
| | GO:2000650 | | negative regulation of sodium ion transmembrane transporter activity | | Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity. |
| | GO:0010766 | | negative regulation of sodium ion transport | | Any process that decreases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0010768 | | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | | Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a UV damage stimulus. |
| | GO:0030948 | | negative regulation of vascular endothelial growth factor receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity. |
| | GO:0007399 | | nervous system development | | The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
| | GO:0007528 | | neuromuscular junction development | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction. |
| | GO:0031175 | | neuron projection development | | The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| | GO:0003151 | | outflow tract morphogenesis | | The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. |
| | GO:0046824 | | positive regulation of nucleocytoplasmic transport | | Any process that activates or increases the frequency, rate or extent of the directed movement of substances between the nucleus and the cytoplasm. |
| | GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| | GO:0045732 | | positive regulation of protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| | GO:0050847 | | progesterone receptor signaling pathway | | Any series of molecular signals generated as a consequence of a progesterone binding to its receptor. |
| | GO:0070534 | | protein K63-linked ubiquitination | | A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation, but is involved in several pathways, notably as a signal to promote error-free DNA postreplication repair. |
| | GO:0006513 | | protein monoubiquitination | | Addition of a single ubiquitin group to a protein. |
| | GO:0006622 | | protein targeting to lysosome | | The process of directing proteins towards the lysosome using signals contained within the protein. |
| | GO:0016567 | | protein ubiquitination | | The process in which one or more ubiquitin groups are added to a protein. |
| | GO:0042787 | | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | | The process in which a ubiquitin group, or multiple groups, are covalently attached to the target protein, thereby initiating the degradation of that protein. |
| | GO:0032801 | | receptor catabolic process | | The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| | GO:0031623 | | receptor internalization | | A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. |
| | GO:0048814 | | regulation of dendrite morphogenesis | | Any process that modulates the frequency, rate or extent of dendrite morphogenesis. |
| | GO:0034765 | | regulation of ion transmembrane transport | | Any process that modulates the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other. |
| | GO:0016241 | | regulation of macroautophagy | | Any process that modulates the frequency, rate or extent of macroautophagy. |
| | GO:0042391 | | regulation of membrane potential | | Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. |
| | GO:1901016 | | regulation of potassium ion transmembrane transporter activity | | Any process that modulates the frequency, rate or extent of potassium ion transmembrane transporter activity. |
| | GO:0050807 | | regulation of synapse organization | | Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell). |
| | GO:0051592 | | response to calcium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
| | GO:0014894 | | response to denervation involved in regulation of muscle adaptation | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a denervation stimulus. This process occurs as part of the regulation of muscle adaptation. |
| | GO:0019089 | | transmission of virus | | The transfer of virions in order to create new infection. |
| | GO:0043162 | | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | | The chemical reactions and pathways resulting in the breakdown of a protein or peptide covalently tagged with ubiquitin, via the multivesicular body (MVB) sorting pathway; ubiquitin-tagged proteins are sorted into MVBs, and delivered to a lysosome/vacuole for degradation. |
| | GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
| cellular component |
|---|
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0016327 | | apicolateral plasma membrane | | The apical end of the lateral plasma membrane of epithelial cells. |
| | GO:0005938 | | cell cortex | | The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
| | GO:0000785 | | chromatin | | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0045121 | | membrane raft | | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| | GO:0005902 | | microvillus | | Thin cylindrical membrane-covered projections on the surface of an animal cell containing a core bundle of actin filaments. Present in especially large numbers on the absorptive surface of intestinal cells. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0000151 | | ubiquitin ligase complex | | A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex. |
Description
